Back to results
Not yet recruitingPhase 3

GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)

NCT05303701

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

View on ClinicalTrials.gov
GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD) — TrialFind